your search results
Simply choose your interests by category and year. You can reduce your result list by deactivating categories you are not interested in.
-
Articles in the press
-
News
-
Press releases
-
Company news
Reducing Risk, Speeding Development — a CDMO Model Including GCP-sponsorship to Better Meet the Needs of Pharma Companies
Pharmaceutical companies are under mounting pressure to develop more user-friendly oral dosage forms. Faced with fierce market competition, they’re also demanding more CDMO support than ever. Can a new type of CDMO offering — one that takes on the responsibility of clinical trial sponsorship — de-risk and accelerate the route to a market-ready product? View this Q&A with Drug Development & Delivery.
HERMES PHARMA announces €25 million investment to bolster capacity
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
HERMES PHARMA Again Achieves Silver CSR Award from EcoVadis
EcoVadis is one of the leading and most trusted provider of business sustainability ratings. The silver medal acknowledges HERMES PHARMA’s continued commitment to sustainable and responsible practices and was awarded on the back of a rigorous review of the company’s business operations.
It Takes Two to Tango: Creating User-friendly Fertility Supplements for Both sexes
Infertility is declining throughout the industrialized world. But as people turn to fertility supplements for a solution, they’re met with inconvenient products. To better support consumers, supplement companies must provide science-backed formulations that are convenient, enjoyable to take long-term, and tailored to the nutritional needs of each sex. However, several manufacturing challenges can complicate the path to success. Article published with NutraIngredients.
Reimagining Vitamin B12 Supplements for the Modern Consumer
Changing lifestyles and demographics mean the risk of vitamin B12 deficiency is growing globally. Traditional vitamin B12 supplements millions rely on, are poorly absorbed and unpleasant to take. To better serve patients and unlock new opportunities, healthcare companies urgently need an alternative — user-friendly vitamin B12 supplements that ensure immediate and continuous vitamin B12 supply. Article published in Nutraceutical Business Review.
Choosing and Developing User-friendly Osmotic Laxatives for a More Patient-centric Portfolio
Constipation is a widespread and growing issue. But most laxative treatments fail to adequately meet patient needs, being unpleasant to take and causing significant side effects. The solution lies in simple, flexible, user-friendly alternatives that put patients first. However, pharmaceutical companies looking to incorporate these alternatives into their portfolio must overcome several formulation and manufacturing challenges. Article in International Pharmaceutical Industry.